Featured Clinical Trial- May Newsletter May 29, 2015 by Kylie Karley Featured Clinical Trial DUET: Sparsentan in FSGS Purpose The DUET trial is an interventional study that will determine how effective the drug Sparsentan is at reducing the urine protein / creatinine ratio over 8 weeks. Who is Eligible? Males and females between the ages of 8 and 75 years old with biopsy proven FSGS, or a proven genetic mutation transplant. Click HERE to see the other criteria that determine who is eligible to participate. How Can I Participate? There are currently over 30 study sites across the United States that are actively recruiting patients! To see that list, click HERE. Don’t see a location near you? No worries! The DUET trial will reimburse you for any travel costs to a study site. All study-related health exams and medications will be provided at no cost. Click HERE to learn more about participating in the DUET Study. Click on the Clinical Trials Finder Map below to see what’s happening near you!